bentracimab
| 3 min read
PhaseBio doses the first patients in Canada with its antiplatelet activity reversal therapy
Page 1 of 1 - 1 Total Items
Subscribe to our eNewsletters
Stay connected with all of the latest from Drug Discovery News.
Subscribe